Henrik N. Kloverpris

Henrik N. Kloverpris

Auto-generated profile, based on publicly available information

Henrik N. Kloverpris

African Health Research Institute , Durban

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2016 in Immunity
Verified
Journal Article
Closed access
YSYannick Simoni
Yannick Simoni
MFMichael Fehlings
Michael Fehlings
HKHenrik N. Kløverpris
Henrik N. Kløverpris
NMNaomi McGovern
Naomi McGovern
SKSi-Lin Koo
Si-Lin Koo
ENEvan W. Newell
Evan W. Newell

1 September 2015 in Immunity
Verified
Journal Article
Closed access
ZNZaza M. Ndhlovu
Zaza M. Ndhlovu
PKPhilomena Kamya
Philomena Kamya
NMNikoshia Mewalal
Nikoshia Mewalal
HKHenrik N. Kløverpris
Henrik N. Kløverpris
TNThandeka Nkosi
Thandeka Nkosi
BWBruce D. Walker
Bruce D. Walker

1 February 2016 in Immunity
Verified
Journal Article
Closed access
HKHenrik N. Kløverpris
Henrik N. Kløverpris
SKSamuel W. Kazer
Samuel W. Kazer
JMJenny Mjösberg
Jenny Mjösberg
JMJenniffer M. Mabuka
Jenniffer M. Mabuka
AWAmanda Wellmann
Amanda Wellmann
ALAlasdair Leslie
Alasdair Leslie

17 May 2021 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
POPaul Ogongo
Paul Ogongo
LTLiku B. Tezera
Liku B. Tezera
AAAmanda Ardain
Amanda Ardain
SNShepherd Nhamoyebonde
Shepherd Nhamoyebonde
DRDuran Ramsuran
Duran Ramsuran
ALAlasdair Leslie
Alasdair Leslie
T cell immunity is essential for the control of tuberculosis (TB), an important disease of the lung, and is generally studied in humans using peripheral blood cells. Mounting evidence, however, indicates that tissue-resident memory T cells (Trms) are superior at controlling many pathogens, including Mycobacterium tuberculosis (M. tuberculosis), and can be quite different from those in circulation. Using freshly resected lung tissue, from individuals with active or previous TB, we identified distinct CD4+ and CD8+ Trm-like clusters within TB-diseased lung tissue that were functional and enriched for IL-17–producing cells. M. tuberculosis–specific CD4+ T cells producing TNF-α, IL-2, and IL-17 were highly expanded in the lung compared with matched blood samples, in which IL-17+ cells were largely absent. Strikingly, the frequency of M. tuberculosis–specific lung T cells making IL-17, but not other cytokines, inversely correlated with the plasma IL-1β levels, suggesting a potential link with disease severity. Using a human granuloma model, we showed the addition of either exogenous IL-17 or IL-2 enhanced immune control of M. tuberculosis and was associated with increased NO production. Taken together, these data support an important role for M. tuberculosis–specific Trm-like, IL-17–producing cells in the immune control of M. tuberculosis in the human lung.

28 September 2016 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
MMMaximilian Muenchhoff
Maximilian Muenchhoff
EAEmily Adland
Emily Adland
OKOwen Karimanzira
Owen Karimanzira
CCCarol Crowther
Carol Crowther
MPMatthew Pace
Matthew Pace
PGPhilip Goulder
Philip Goulder
Pediatric HIV patients who do not rapidly develop AIDS are shown to have immunological features similar to nonhuman primates that experience nonpathogenic SIV infection.

30 May 2016 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
LTLance Turtle
Lance Turtle
TBTanushka Bali
Tanushka Bali
GBGemma Buxton
Gemma Buxton
SCSavita Chib
Savita Chib
SCSajesh Chan
Sajesh Chan
TSTom Solomon
Tom Solomon
Japanese encephalitis (JE) virus (JEV) is an important cause of encephalitis in children of South and Southeast Asia. However, the majority of individuals exposed to JEV only develop mild symptoms associated with long-lasting adaptive immunity. The related flavivirus dengue virus (DENV) cocirculates in many JEV-endemic areas, and clinical data suggest cross-protection between DENV and JEV. To address the role of T cell responses in protection against JEV, we conducted the first full-breadth analysis of the human memory T cell response using a synthetic peptide library. Ex vivo interferon-γ (IFN-γ) responses to JEV in healthy JEV-exposed donors were mostly CD8+ and targeted nonstructural (NS) proteins, whereas IFN-γ responses in recovered JE patients were mostly CD4+ and targeted structural proteins and the secreted protein NS1. Among patients, a high quality, polyfunctional CD4+ T cell response was associated with complete recovery from JE. T cell responses from healthy donors showed a high degree of cross-reactivity to DENV that was less apparent in recovered JE patients despite equal exposure. These data reveal divergent functional CD4+ and CD8+ T cell responses linked to different clinical outcomes of JEV infection, associated with distinct targeting and broad flavivirus cross-reactivity including epitopes from DENV, West Nile, and Zika virus.